RARA and acute promyelocytic leukemia: Surprisingly, unlike in APL, RARA fusions have never been identified in neuroblastoma13, and while RA can certainly induce differentiation in neuroblastoma cell lines in vitro10, its use in the maintenance therapy setting (typically minimal residual disease) makes it difficult to prove that differentiation is the primary mechanism of its activity in patients.